Tumor-induced osteomalacia (TIO) is an uncommon paraneoplastic syndrome characterized by overproduction of FGF-23 by the tumor as well as inappropriately normal or low levels of vitamin D due to impaired hydroxylation leading to phosphate wasting by the kidney and eventual hypophosphatemia (Figure 1) [35-40]. The gene discussed is FGF23; the disease is neoplasm.